Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
CANCERS
Authors: Priebe, Valdemar; Sartori, Giulio; Napoli, Sara; Chung, Elaine Yee Lin; Cascione, Luciano; Kwee, Ivo; Arribas, Alberto Jesus; Mensah, Afua Adjeiwaa; Rinaldi, Andrea; Ponzoni, Maurilio; Zucca, Emanuele; Rossi, Davide; Efremov, Dimitar; Lenz, Georg; Thome, Margot; Bertoni, Francesco
Abstract
Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expression profiling. A recurrent ch11q24.3 gain is observed in roughly a fourth of DLBCL cases resulting in the overexpression of two ETS transcription factor family members, ETS1 and FLI1. Here, we knocked down ETS1 expression by siRNA and analyzed expression changes integrating them with ChIP-seq data to identify genes directly regulated by ETS1. ETS1 silencing affected expression of genes involved in B cell signaling activation, B cell differentiation, cell cycle, and immune processes. Integration of RNA-Seq (RNA sequencing) data and ChIP-Seq (chromatin immunoprecipitation sequencing) identified 97 genes as bona fide, positively regulated direct targets of ETS1 in ABC-DLBCL. Among these was the Fc receptor for IgM, FCMR (also known as FAIM3 or Toso), which showed higher expression in ABC- than GCB-DLBCL clinical specimens. These findings show that ETS1 is contributing to the lymphomagenesis in a subset of DLBCL and identifies FCMR as a novel target of ETS1, predominantly expressed in ABC-DLBCL.
The Old but New IgM Fc Receptor (Fc mu R)
FC RECEPTORS
Authors: Kubagawa, Hiromi; Kubagawa, Yoshiki; Jones, Dewitt; Nasti, Tahseen H.; Walter, Mark R.; Honjo, Kazuhito
Abstract
IgM is the first Ig isotype to appear during phylogeny, ontogeny and the immune response. The importance of both pre-immune "natural" and antigen-induced "immune" IgM antibodies in immune responses to pathogens and self-antigens has been established by studies of mutant mice deficient in IgM secretion. Effector proteins interacting with the Fc portion of IgM, such as complement and complement receptors, have thus far been proposed, but fail to fully account for the IgM-mediated immune protection and regulation of immune responses. Particularly, the role of the Fc receptor for IgM (Fc mu R) in such effector functions has not been explored until recently. We have identified an authentic Fc mu R in humans using a functional cloning strategy and subsequently in mice by RT-PCR and describe here its salient features and the immunological consequences of Fc mu R deficiency in mice. Since the Fc mu R we cloned was identical to Toso or Fas inhibitory molecule 3 (FAIM3), there have been spirited debates regarding the real function of Fc mu R/Toso/FAIM3 and we will also comment on this topic.